WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'1301 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 13'8011 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 48'653  48'229  47'792  47'343  46'881  40'404  34'272  27'738 
Births 739  746  754  761  768  848  905  881 
Surviving infants 727  734  741  747  755  829  877  837 
Pop. less than 5 years 3'712  3'738  3'770  3'797  3'826  4'152  4'341  3'986 
Pop. less than 15 years 11'622  11'713  11'805  11'882  11'951  12'740  12'465  11'262 
Female 15-49 years 13'256  13'204  13'147  13'084  13'011  11'207  9'018  6'780 

Number of reported cases

(Click for retrospective incidence data for Colombia)
Diphtheria
ChartChart
  11  16 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  12'520  9'222 
Mumps
ChartChart
  10'452  6'573  7'368  7'884  9'377 
Pertussis
ChartChart
  536  986  734  13'682  3'289  446  1'961  7'664 
Polio*
ChartChart
  129 
Rubella
ChartChart
  157 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10  133 
Tetanus (total)**
ChartChart
  45  48  59  31  50  27  167  593 
Yellow fever
ChartChart
  11 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Colombia)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS   83  88  90  89  85  89  91  95  45 
DTP1 2009  97  DHS   83  93  93  91  89  91  75 
DTP3 2009  90  DHS   83  91  91  90  91  91  79  88  16 
DTP4          86  93  90 
IPV1          93  92 
HepB_BD          87  86  82  85  82 
HepB3 2009  90  DHS   83  91  91  90  91  92  78 
Hib3 2009  90  DHS   83  91  91  90  91  91  65 
JapEnc         
MCV1          93  94  91  92  94  80  82  13 
MCV2          87  86  88  72  79  84 
MenA         
PCV1          91  93  91  89  94 
PCV2          90  91  90  90  91 
PCV3          89  91  89  87  84 
Pol3 2009  82  DHS   83  91  91  90  91  91  82  93  16 
Rota1          90  90  89  86  88 
RotaC          90  91  89  87  87 
RCV1          93  94  91  92  94 
TT2plus 1994  57  DHS   47  58  51  33  33  42 
PAB          79  60 
VAD1         
YFV 2009  77  DHS   83  77  54  92  92  92 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Colombia)
BCG
ChartChart
  88  90  89  85  89  91  95  45 
DTP1
ChartChart
  93  93  91  97  91  91  96  39 
DTP3
ChartChart
  91  91  90  91  91  79  88  16 
HepB3
ChartChart
  91  91  90  91  92  78 
HepB_BD
ChartChart
 
Hib3
ChartChart
  91  91  90  91  91  65 
IPV1
  92  92 
MCV1
ChartChart
  93  94  91  92  94  88  82  13 
MCV2
ChartChart
  87  86  88  72  80  84 
PCV3
ChartChart
  89  91  89  87  84 
Pol3
ChartChart
  91  91  90  91  91  82  93  16 
RCV1
ChartChart
  93  94  91  92  94  88 
RotaC
ChartChart
  90  91  89  87  87 
YFV
ChartChart
  92  92  92  92  92 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 1'122  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 53
From 80 to 89% 25
From 50 to 79% 20
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 5 years; children with pertussis contraindication
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepA_Adult Yes Se aplica a víctimas de violencia sexual sin importar la edad de la víctima
HepA_Pediatric 1 year; Yes
HepB_Pediatric birth; Yes
HPV 9-17 years; +6 months; Yes
Influenza_Adult >= 50 years; Yes pregnant women, adults with chronic diseases, health care workers
Influenza_Pediatric 6-23 months; Yes and children with chronic diseases
IPV 2 months; Yes
MenACWY-135 conj 2, 4, 6 months; Yes in case of outbreak
MMR 1, 5 years; Yes
MR 1-39 years; Yes Los grupos a vacunaren el país es a colombianos que van al exterior y solcitan la vacuan a libre demanda , así como len la detección de susceptibles de 11 a 39 años, en el proceso de MRCV y BAC en caso sospechosos de SR reportado
OPV 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rabies Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months;+1, +1 years; Yes adults
Tdap Yes Pregnant women from week 24
Varicella 1 year; Yes
YF 12-18 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2010-2014  2014-2019  2010-2014    2011-2014 
Nº of districts with microplans that include activities to raise immunization coverage number 1'122  1'122      80  1'123  1'123 

System performance

Total Nº districts in country number 1'122  1'122  1'122  1'122  1'122  1'123  1'123 
Nº districts with DTP3 coverage >=80% number 884  835  733  710  853  474  551 
% of districts with DTP3 coverage >=80% From 0 to 100% 79  74  65  63  76  42  49 
Nº districts with measles (MCV1) coverage >=95% number 441  400  310  393  480  288  277 
% of districts with MCV1 coverage >=95% From 0 to 100% 39  36  28  35  43  26  25 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.